The PLASMIC score to predict TTP associated with severe ADAMTS13 deficiency
| Investigation . | Point . |
|---|---|
| Platelet count < 30 × 109/L | 1 |
| Hemolysis variable* | 1 |
| No active cancer | 1 |
| No history of HSCT | 1 |
| MCV < 90 fL | 1 |
| INR < 1.5 | 1 |
| Creatinine < 2.0 mg/dL | 1 |
| Investigation . | Point . |
|---|---|
| Platelet count < 30 × 109/L | 1 |
| Hemolysis variable* | 1 |
| No active cancer | 1 |
| No history of HSCT | 1 |
| MCV < 90 fL | 1 |
| INR < 1.5 | 1 |
| Creatinine < 2.0 mg/dL | 1 |
INR, international normalized ratio; MCV, mean cell volume. Reprinted from Bendapudi et al48 with permission.
Reticulocyte count >2.5% or undetectable haptoglobin or indirect bilirubin >2.0 mg/dL.